TGFB2 and glioblastoma: To examine the effects of the downstream components of the TGFβ2/Smads signaling pathway, Smad2 and Smad3, on GBM cell proliferation, the present study transfected U251 cells with shRNAs, to selectively deplete Smad2 and Smad3, and measured the growth of the cells.